Toll Free: 1-888-928-9744

Global Erythropoietin (EPO) Market Outlook 2016-2021

Published: Nov, 2016 | Pages: 129 | Publisher: Gen Consulting Company
Industry: Biotechnology | Report Format: Electronic (PDF)

Erythropoietin, also known as EPO, hematopoietin, or hemopoietin, is a glycoprotein hormone that controls erythropoiesis, or red blood cell production. It is a cytokine (protein signaling molecule) for erythrocyte (red blood cell) precursors in the bone marrow. Human EPO has a molecular weight of 34 kDa.

Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. While liver production predominates in the fetal and perinatal period, renal production is predominant during adulthood.

Exogenous erythropoietin can be provided to people whose kidneys cannot make enough. Recombinant human erythropoietin (rhEPO) is produced by recombinant DNA technology in cell culture. Several different pharmaceutical agents are available with a variety of glycosylation patterns and are collectively called erythropoiesis-stimulating agents (ESA). Major examples are epoetin alfa and epoetin beta. The specific details for labeled use vary between the package inserts, but ESAs have been used in the treatment of anemia in chronic kidney disease, anemia in myelodysplasia, and in anemia from cancer chemotherapy. Boxed warnings include a risk of death, myocardial infarction, stroke, venous thromboembolism, and tumor recurrence. rhEPO has been used illicitly as a performance-enhancing drug; it can often be detected in blood, due to slight differences from the endogenous protein, for example, in features of posttranslational modification.

This report provides detailed analysis of worldwide markets for Erythropoietin (EPO) from 2011-2015 and provides extensive market forecasts 2016-2021 by region/country and subsectors. It covers the key technological and market trends in the Erythropoietin (EPO) market and further lays out an analysis of the factors influencing the supply/demand for Erythropoietin (EPO), and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.

GCC's report, Global Erythropoietin (EPO) Market Outlook 2016-2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Erythropoietin (EPO) market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Erythropoietin (EPO) market are Amgen (USA), Johnson & Johnson (USA), Roche (Switzerland), Kyowa Hakko Kirin (Japan), 3SBIO (China), among others.

The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Erythropoietin (EPO) industry has been provided.
 Table of Contents
Part 1. Exclusive Summary Part 2. Methodology 2.1 Research Methodology 2.2 Geographic Scope 2.3 Years Considered Part 3. Introduction 3.1 Definition 3.2 Supply Chain Structure 3.2.1 Raw Material Supply 3.2.2 Traders & Distributors 3.2.3 Key Customers 3.3 Manufacture 3.3.1 Manufacturing Process 3.3.2 Production Cost Part 4. Market Landscape 4.1 Global Erythropoietin (EPO) Market Size (Volume) 2011-2016 4.1.1 Overview 4.1.2 Global Erythropoietin (EPO) Production 4.1.3 Top 10 Erythropoietin (EPO) Companies (Volume Share) 4.2 Global Erythropoietin (EPO) Market Size (Value) 2011-2016 4.2.1 Overview 4.2.2 Global Erythropoietin (EPO) Production Value 4.2.3 Top 10 Erythropoietin (EPO) Companies (Revenue Share) Part 5. Segmentation by Products 5.1 Type 1 5.2 Type 2 5.3 Type 3 Part 6. Segmentation by End-users 6.1 Customer Segment 1 6.2 Customer Segment 2 6.3 Customer Segment 3 6.4 Customer Segment 4 Part 7. Geographical Segmentation 7.1 North America Erythropoietin (EPO) Market 7.1.1 North America Market Overview 7.1.2 North America Price & Margin 7.1.3 North America Trade Balance 7.2 EMEA Erythropoietin (EPO) Market 7.2.1 EMEA Market Overview 7.2.2 EMEA Price & Margin 7.2.3 EMEA Trade Balance 7.3 Asia Pacific Erythropoietin (EPO) Market 7.3.1 Asia Pacific Market Overview 7.3.2 Asia Pacific Price & Margin 7.3.3 Asia Pacific Trade Balance Part 8. Market Forecast 8.1 Market Size by Volume 2016-2021 8.1.1 North America 8.1.2 EMEA 8.1.3 Asia-Pacific 8.1.4 RoW 8.2 Market Size by Value 2016-2021 8.2.1 North America 8.2.2 EMEA 8.2.3 Asia-Pacific 8.2.4 RoW 8.3 Regional Consumption Forecast 8.3.1 North America 8.3.2 EMEA 8.3.3 Asia-Pacific 8.3.4 RoW 8.4 Consumption Forecast by End-users 8.5 Consumption Forecast by Products Part 9. Company Profiles 9.1 Company A 9.1.1 Overview 9.1.2 Products Offered 9.1.3 Business Performance 9.2 Company B 9.3 Company C 9.4 Company D Part 10. Market Dynamics 10.1 Market Drivers 10.2 Market Constraints 10.3 Market Strategies Part 11. Competitive Landscape 11.1 Mergers & Acquisitions 11.2 New Product Launches 11.3 Expansions 11.4 Other Developments Part 12. Appendix Disclaimer Analysts Certification List of Tables and Figures
Figure Global Production 2011-2016 Figure Global Production Value (M USD) 2011-2016 Figure Top 10 Players Revenue Share 2015 Figure Regional Production 2015 Figure Regional Production Value (M USD) 2015 Figure Global Consumption by End Market 2015 Figure Erythropoietin (EPO) Product Figure Supply Chain Structure of Erythropoietin (EPO) Table Raw Materials Used for Erythropoietin (EPO) Production Table Traders & Distributors of Erythropoietin (EPO) Table Key Customers of Erythropoietin (EPO) Figure Erythropoietin (EPO) Manufacturing Process Flow Figure Erythropoietin (EPO) Production Cost Structure Figure Global Erythropoietin (EPO) Market, Growth Rate Table Global Key Vendors Production 2011-2016 Table Global Key Vendors Production Market Share 2011-2016 Figure Global Production, Capacity Utilization 2011-2016 Figure Top 10 Companies Market Share Trends Table Global Top 10 Vendors Production 2011 Table Global Top 10 Vendors Production 2012 Table Global Top 10 Vendors Production 2013 Table Global Top 10 Vendors Production 2014 Table Global Top 10 Vendors Production 2015 Table Global Top 10 Vendors Production 2016 Figure Global Erythropoietin (EPO) Market (M USD), Growth Rate & CAGR Table Global Key Vendors Production Value (M USD) 2011-2016 Table Global Key Vendors Production Value Market Share 2011-2016 Figure Top 10 Player Market Share Trends Table Global Top 10 Vendors Production Value (M USD) 2011 Table Global Top 10 Vendors Production Value (M USD) 2012 Table Global Top 10 Vendors Production Value (M USD) 2013 Table Global Top 10 Vendors Production Value (M USD) 2014 Table Global Top 10 Vendors Production Value (M USD) 2015 Table Global Top 10 Vendors Production Value (M USD) 2016 Figure Prices of Major Players 2016 Figure Gross Margin of Major Players 2016 Table Types of Erythropoietin (EPO) Figure Global Production Market Share of Erythropoietin (EPO) by Types in 2015 Table Type 1 Erythropoietin (EPO) Production 2011-2016 Table Type 1 Erythropoietin (EPO) Price Trends 2011-2016 Table Major Manufacturers of Type 1 Erythropoietin (EPO) Table Type 2 Erythropoietin (EPO) Production 2011-2016 Table Type 2 Erythropoietin (EPO) Price Trends 2011-2016 Table Major Manufacturers of Type 2 Erythropoietin (EPO) Table Type 3 Erythropoietin (EPO) Production 2011-2016 Table Type 3 Erythropoietin (EPO) Price Trends 2011-2016 Table Major Manufacturers of Type 3 Erythropoietin (EPO) Figure Global Erythropoietin (EPO) Market by Key Customer Segments 2015 Table Erythropoietin (EPO) Consumed for Customer Segment 1 Table Key Customers of Erythropoietin (EPO) Table Erythropoietin (EPO) Consumed for Customer Segment 2 Table Key Customers of Erythropoietin (EPO) Table Erythropoietin (EPO) Consumed for Customer Segment 3 Table Key Customers of Erythropoietin (EPO) Figure Global Erythropoietin (EPO) Market Segmentation by Geography 2015 Figure North America Erythropoietin (EPO) Capacity & Production 2011-2016 Figure North America Erythropoietin (EPO) Revenue (M USD) 2011-2016 Figure North America Erythropoietin (EPO) Price & Margin 2011-2016 Table North America Erythropoietin (EPO) Trade Balance Figure North America Erythropoietin (EPO) Self-sufficiency Figure EMEA Erythropoietin (EPO) Capacity & Production 2011-2016 Figure EMEA Erythropoietin (EPO) Revenue (M USD) 2011-2016 Figure EMEA Erythropoietin (EPO) Price & Margin 2011-2016 Table EMEA Erythropoietin (EPO) Trade Balance Figure EMEA Erythropoietin (EPO) Self-sufficiency Figure Asia Pacific Erythropoietin (EPO) Capacity & Production 2011-2016 Figure Asia Pacific Erythropoietin (EPO) Revenue (M USD) 2011-2016 Figure Asia Pacific Erythropoietin (EPO) Price & Margin 2011-2016 Table Asia Pacific Erythropoietin (EPO) Trade Balance Figure Asia Pacific Erythropoietin (EPO) Self-sufficiency Figure Global Production Volume Forecast 2016-2021 Table Global Production Volume 2016-2021 Table Global Production Volume Share 2016-2021 Figure North America Erythropoietin (EPO) Production Volume Forecast Figure Global Production Value (M USD) 2016-2021 Table Global Production Value (M USD) 2016-2021 Table Global Production Value Share 2016-2021 Figure North America Erythropoietin (EPO) Production Value (M USD) Forecast Figure Regional Consumption 2021 Table Consumption Volume by Region 2016-2021 Table Consumption Volume Share by Region 2016-2021 Figure North America Consumption 2016-2021 Figure Consumption by Key Customer Segments 2021 Table Global Erythropoietin (EPO) Market by Customer Segments 2016-2021 (Volume) Table Global Erythropoietin (EPO) Market by Customer Segments 2016-2021 (Share) Figure Consumption by Types 2021 Table Global Consumption Volume by Types 2016-2021 Table Global Consumption Volume Share by Types 2016-2021 Table Financial Performance 2011-2016 Figure Market Share Trend 2011-2016

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $2800
Multi User - US $5600
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify